Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Sales | 8,300 | 4,495 | 7,216 | 6,539 | 6,129 |
| Cost of Goods | 276 | 152 | 221 | 221 | 252 |
| Gross Profit | 8,024 | 4,343 | 6,995 | 6,318 | 5,877 |
| Operating Expenses | 44,016 | 138,227 | 41,508 | 36,308 | 35,418 |
| Operating Income | -35,716 | -133,732 | -34,292 | -29,769 | -29,289 |
| Interest Expense | 2,704 | 2,723 | 2,759 | 2,741 | 1,938 |
| Other Income | 963 | 60 | 384 | 391 | 451 |
| Pre-tax Income | -37,457 | -136,395 | -36,667 | -32,119 | -30,776 |
| Net Income Continuous | -37,457 | -136,395 | -36,667 | -32,119 | -30,776 |
| Net Income | $-37,457 | $-136,395 | $-36,667 | $-32,119 | $-30,776 |
| EPS Basic Total Ops | -8,998.20 | -32,993.40 | -12,957.41 | -11,517.70 | -11,157.77 |
| EPS Basic Continuous Ops | -9,051.06 | -33,021.48 | -13,044.51 | -11,467.07 | -11,132.36 |
| EPS Diluted Total Ops | -8,998.20 | -32,993.40 | -12,957.41 | -11,517.70 | -11,157.77 |
| EPS Diluted Continuous Ops | -9,051.06 | -33,021.48 | -13,044.51 | -11,467.07 | -11,132.36 |
| EBITDA(a) | $-32,998 | $-130,550 | $-32,004 | $-27,644 | $-27,292 |